Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BankTheTrade Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::864584576.png) Palmer [@BankTheTrade](/creator/twitter/BankTheTrade) on x 8954 followers
Created: 2025-07-14 12:07:06 UTC

$DARE XXXX up X announced positive interim safety and efficacy results from its ongoing        Phase X clinical trial evaluating the contraceptive effectiveness,        safety and acceptability of Ovaprene®, the company’s investigational        monthly, hormone-free intravaginal contraceptive. There currently are no        FDA-approved, hormone-free, monthly intravaginal contraceptives.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944730372601696475/c:line.svg)

**Related Topics**
[$dare](/topic/$dare)

[Post Link](https://x.com/BankTheTrade/status/1944730372601696475)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BankTheTrade Avatar Palmer @BankTheTrade on x 8954 followers Created: 2025-07-14 12:07:06 UTC

$DARE XXXX up X announced positive interim safety and efficacy results from its ongoing Phase X clinical trial evaluating the contraceptive effectiveness, safety and acceptability of Ovaprene®, the company’s investigational monthly, hormone-free intravaginal contraceptive. There currently are no FDA-approved, hormone-free, monthly intravaginal contraceptives.

XXX engagements

Engagements Line Chart

Related Topics $dare

Post Link

post/tweet::1944730372601696475
/post/tweet::1944730372601696475